Document:

Prepared and filed by St Ives Burrups

Exhibit 10.1

 

	SECURITIES PURCHASE AGREEMENT

THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”),
    is made and entered into as of October 16, 2003, by and among Trikon Technologies,
    Inc., a Delaware corporation (the “Company”), and the undersigned
    investor (the “Investor”) who is
 subscribing for shares of common stock, par value $0.001 per share (the “Common Stock”)
 of the Company and warrants to purchase shares of Common Stock. For the purposes
 of this Agreement: (i) a “Unit” shall mean (A) four shares
 of Common Stock and (B) one warrant, substantially in the form attached hereto
 as Exhibit A, as the same may be amended, modified or supplemented from
 time to time in accordance with the terms thereof (the “Warrant”),
 each entitling the holder thereof to purchase one share of Common Stock (subject
 to adjustment as provided in the Warrant); and (ii) “Unit Common Stock” shall
 mean the shares of Common Stock issued and sold by the Company hereunder.

	ARTICLE I

      

        PURCHASE AND SALE OF UNITS; CLOSING

1.1     Purchase and Sale of the Units.

(a)     Subject
    to the terms and conditions of this Agreement, the Investor agrees to purchase
    from the Company and the Company agrees to issue and sell to the Investor
    the number of Units indicated on the signature page hereto (the “Subscription
    Amount”) at a purchase price of $20.00 per Unit for an aggregate
    purchase price indicated on the signature page hereto (the “Aggregate
    Purchase Price”).

1.2     Delivery of Units at Closing.
    Upon confirmation that the conditions of Closing specified herein (other
    than payment of the Aggregate Purchase Price), the Company shall deliver
    to Lowenstein Sandler PC, in trust, a certificate or certificates, registered
    in such name or names as the Investor may designate, representing the Unit
    Common Stock and the Warrants, with instructions that such certificates are
    to be held for release to the Investor only upon payment of the Aggregate
    Purchase Price to the Company. Upon receipt by Lowenstein
 Sandler PC of the certificate or certificates, the Investor shall promptly,
    and in no event later than 2 business days, cause a wire transfer in same
    day funds to be sent to the account of the Company as instructed in writing
    by the Company, in an amount equal to the Aggregate Purchase Price. On the
    date the Company receives such funds, the certificates evidencing the Unit
    Common Stock and Warrants shall be released to the Investor (the “Closing”).
    The purchase and sale of the Units shall take place at the offices of Lowenstein
    Sandler PC, 1330 Avenue of the Americas, 21st Floor, New York, New York,
    or such other date or place agreed to by the parties. The date upon which
  the Closing actually occurs is herein referred to as the “Closing Date”.

1.3     Conditions
      to the Company’s Obligation to Complete Purchase and Sale. The
      Company’s obligation to issue and sell the Units to the Investor at
      Closing is subject to the satisfaction, on or before the Closing Date,
      of each of the following conditions, provided that
 these conditions are for

 

1

the Company’s sole benefit and
    may be waived by the Company at any time in its sole discretion by providing
the Investor with prior written notice thereof:

(a)     Payment of Purchase
    Price. The Investor shall have delivered the Aggregate Purchase Price
    to the Company in accordance with Section 1.2; and
    
    (b)     Representations
          and Warranties; Covenants. The representations and warranties of
          the Investor set forth in Article III hereof qualified as to materiality
          shall be true and correct at all times from the date hereof to and
          on the Closing Date, except to the extent any such representation or
          warranty expressly speaks as of an earlier date, in which case such
          representation or warranty shall be true and correct as of such earlier
          date, and, the representations and warranties of the Investor set forth
          in Article III hereof not qualified as to materiality shall be true
          and correct in all material respects at all times from the date hereof
          to and on the Closing Date, except to the extent any such representation
          or warranty expressly speaks as of an earlier date, in which case such
          representation or warranty shall be true and correct in all material
          respects as of such earlier date, and the Investor shall have performed,
          satisfied and complied with in all material respects the covenants,
          agreements and conditions required by this Agreement to be performed,
          satisfied or complied with by the Investor on or prior to the Closing
          Date.

    
     

1.4     Conditions
      to the Investor’s Obligation to Complete Purchase and Sale. The
      obligation of the Investor hereunder to purchase the Units from the Company
      at the Closing is subject to the satisfaction, on or before the Closing
      Date, of each of the following conditions, provided that these conditions
      are for the Investor’s sole benefit and may be waived by the Investor
      at any time in its sole discretion by providing the Company with prior
      written notice thereof:

(a)     Opinion of Counsel.
  Receipt by the Investor of an opinion letter of Wilson Sonsini Goodrich & Rosati,
  Professional Corporation, counsel to the Company, dated the Closing Date, in
  substantially the form attached hereto as Exhibit B;
    
  

    (b)     Representations
          and Warranties; Covenants. The representations and warranties of
          the Company set forth in Article II hereof qualified as to materiality
          shall be true and correct at all times from the date hereof to and
          on the Closing Date, except to the extent any such representation or
          warranty expressly speaks as of an earlier date, in which case such
          representation or warranty shall be true and correct as of such earlier
          date, and, the representations and warranties of the Company set forth
          in Article II hereof not qualified as to materiality shall be true
          and correct in all material respects at all times from the date hereof
          to and on the Closing Date, except to the extent any such representation
          or warranty expressly speaks as of an earlier date, in which case such
          representation or warranty shall be true and correct in all material
          respects as of such earlier date, and the Company shall have performed,
          satisfied and complied with in all material respects the covenants,
          agreements and conditions required by this Agreement to be performed,
          satisfied or complied with by the Company on or prior to the Closing
          Date;

    (c)     Officer’s
          Certificate. The Company shall have delivered to the Investor a
          certificate, dated the Closing Date, duly executed on behalf of the
          Company by its Chief Executive Officer to the effect set forth in clause
          (b) above and clauses (e) and (f) below;

     

 

2

(d)     Secretary’s
    Certificate. The Company shall have delivered to the Investor a certificate,
    dated the Closing Date, duly executed by its Secretary or Assistant Secretary,
    certifying that the attached copies of the Company’s certificate of
    incorporation, by-laws and the resolutions of the Board of Directors of the
    Company approving this Agreement and the transactions contemplated hereby,
    are all true, complete and correct and remain unamended and in full force
    and effect; and 
  

    (e)     No
          Litigation. On the Closing Date, no legal action, suit or proceeding
          shall be pending or overtly threatened which seeks to restrain or prohibit
          the transactions contemplated by this Agreement.

    (f)     No
          Stop Order. No stop order or suspension of trading shall have been
          imposed by Nasdaq National Market (as defined below), the U.S. Securities
          and Exchange Commission (the “SEC”) or any other governmental
          regulatory body with respect to public trading in the Common Stock.

1.5     Termination.
    This Agreement shall be terminated and of no force and effect whatsoever
    if the Closing does not occur on or before November 30, 2003, provided, however,
    that such termination shall not relieve any party hereto of any liability
    such party may have for any breach of a representation, warranty, covenant
    or agreement contained herein prior to such termination.

 

	ARTICLE II

      

        REPRESENTATIONS AND WARRANTIES OF THE COMPANY

Except as set forth on the Schedule of Exceptions attached hereto as Schedule A, the Company hereby represents and warrants to the Investor as follows:

2.1     Subsidiaries; Organization.
    The Company has no subsidiaries (as defined by Rule 405 under the Securities
    Act of 1933, as amended (the “Securities Act)) except as set
    forth in Exhibit 21 to its Annual Report on Form 10-K for the fiscal year
    ended December 31, 2002 (the “Subsidiaries”). The Company
    and each of its Subsidiaries is duly organized and validly existing and is
    in good standing under the laws of the jurisdiction of its incorporation
    or organization. The Company and each of its Subsidiaries has full corporate
    power and authority to own, operate and occupy its properties and to conduct
    its business as presently conducted and is registered or qualified to do
    business and in good standing in each jurisdiction in which it owns or leases
    property or transacts business and where the failure to be so
 qualified has had or would reasonably be expected to have a material adverse
    effect upon the business, assets, financial condition, results of operation
    or prospects of the Company and its Subsidiaries taken as a whole (a “Material Adverse Effect”), and to the Company’s
    knowledge, no proceeding has been instituted in any such jurisdiction revoking,
    limiting or curtailing, or seeking to revoke, limit or curtail, such power
    and authority or qualification. For the purposes of this Agreement, the term “knowledge” means, with respect to the
 Company, the current actual knowledge of the Company’s executive officers.

2.2     Due Authorization. The Company has all requisite corporate power and authority to execute and deliver this Agreement, to issue and sell the Unit Common Stock and the Warrants and to perform its other obligations hereunder, all of which has been duly
 authorized by all necessary

 

3

corporate action. Each of this Agreement
    and the Warrant has been duly authorized and validly executed and delivered
    by the Company and, assuming due authorization, execution and delivery by
    the other party hereto, constitutes a valid and legally binding obligation
    of the Company enforceable against the Company in accordance with its terms,
    except (i) to the extent rights to indemnity and contribution may be limited
    by state or federal securities laws or the public policy underlying such
    laws, (ii) enforceability may be limited by applicable
 bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or
    similar laws affecting creditors’ and contracting parties’ rights
    generally and (iii) enforceability may be limited by general principles of
    equity (regardless of whether such enforceability is considered in a proceeding
 in equity or at law).

2.3     Non-Contravention.
    The execution and delivery of this Agreement, the issuance and sale of the
    Unit Common Stock and Warrants to be sold by the Company under this Agreement,
    the issuance of the Warrant Shares (as defined below) upon exercise of the
    Warrants, the performance by the Company of its obligations under this Agreement
    and the consummation of the transactions contemplated hereby will not (A)
    conflict with or constitute a violation of, or default (with or without the
    giving of notice or the passage of time or
 both) under, (i) any bond, debenture, note or other evidence of indebtedness,
    or under any material lease, indenture, mortgage, deed of trust, loan agreement,
    joint venture or other agreement or instrument to which the Company is a
    party or by which it or its properties are bound, except where such violation
    or default, individually or in the aggregate, would not reasonably be expected
    to result in a Material Adverse Effect on the Company or its Subsidiaries
    taken as a whole, (ii) the charter, by-laws or other organizational documents
    of the
 Company or any of its Subsidiaries, or (iii) any law, administrative regulation,
    ordinance or order of any court or governmental agency, arbitration panel
    or authority applicable to the Company, any of its Subsidiaries or their
    respective properties, or (B) result in the creation or imposition of any
    material lien, encumbrance, claim, security interest or restriction whatsoever
    upon any of the material properties or assets of the Company or any of its
    Subsidiaries or an acceleration of indebtedness pursuant to any obligation,
    agreement or condition
 contained in any material bond, debenture, note or any other evidence of indebtedness
    or any material indenture, mortgage, deed of trust or any other agreement
    or instrument to which the Company or any of its Subsidiaries is a party
    or by which the Company or any of its Subsidiaries is bound or to which any
    of the property or assets of the Company or any of its Subsidiaries is subject.
    No consent, approval, authorization or other order of, or registration, qualification
    or filing with, any regulatory body, administrative agency, self-regulatory
    organization, stock exchange or market, or other governmental body in the
    United States or the United Kingdom or any third person is required for the
    execution and delivery of this Agreement and the valid issuance and sale
    of the Units to be sold pursuant to this Agreements,
 other than such as have been made or obtained, and except for any post-sale
    securities filings required to be made under federal or state securities
  laws, which will be made when required.

2.4     Reporting Status.
    The Company has filed in a timely manner all documents that the Company was
    required to file under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), during the 12 months preceding the date of this Agreement. The
 following documents complied as to form in all material respects with the SEC’s
 requirements as of their respective filing dates, and the information contained
 therein as of the date thereof did not contain an untrue statement of a material
 fact or omit to state a material fact required to be stated therein or necessary
 to make the statements therein, in light of the circumstances under which they
 were made,

 

4

not misleading, except to the extent that information contained in any such document has been revised or superseded by a later filed SEC Document (as defined below):

(a)     The Company’s
  Proxy Statement for the 2002 Annual Meeting of Stockholders (the “Proxy
  Statement”); 
  

    (b)     The
        Company’s Annual Report on Form 10-K for the fiscal year ended December
        31, 2002 (the “Form 10-K”); and

    (c)     The
        Company’s Quarterly Reports on Form 10-Q for the fiscal quarters
        ended March 31, 2003 and June 30, 2003 (the “Form 10-Qs”);
        and

    (d)     all
        other documents, including the exhibits thereto, filed by the Company
        with the SEC since December 31, 2002 and prior to the date hereof pursuant
        to the reporting requirements of the Exchange Act (together with the
        Proxy Statement, the Form 10-K and Form 10-Qs, the “SEC Documents”).

    
     

2.5     Capitalization.
    As of the date hereof, the authorized capital stock of the Company consists
    of 70,000,000 shares of capital stock, of which 50,000,000 shares are designated
    Common Stock and 20,000,000 shares are designated Preferred Stock. As of
    September 24, 2003, there were approximately 14,127,568 shares of Common
    Stock issued and outstanding, and no shares of Preferred Stock issued and
    outstanding. As of September 24, 2003 an aggregate of 2,400,000 shares of
    Common Stock were reserved for issuance under the Company’s 1991 Stock
    Option Plan and the 1998 Non-Employee Directors Stock Option Plan. As of
    September 24, 2003, 1,815,187 shares issuable upon exercise of outstanding
    stock options issued by the Company to employees, consultants and directors
    of the Company. As of September 24, 2003, 92,593 shares of Common Stock were
    reserved for issuance upon exercise of warrants issued by the Company. All
    outstanding shares of Common Stock are duly authorized, validly issued, fully
    paid and nonassessable and were issued in compliance with federal and U.S.
    state securities laws. Other than as disclosed in the SEC Documents, and
    except as set forth above, there are no outstanding rights, options, warrants,
    preemptive rights, rights of first refusal, agreements, commitments or similar
    rights for the purchase or acquisition from the Company or any of its Subsidiaries
    of any securities of the Company or any of its Subsidiaries. The shares of
    Unit Common Stock to be sold pursuant to this Agreement have been duly authorized,
    and when issued and paid for in accordance with the terms of this Agreement
    will be validly issued, fully paid and nonassessable and free and clear of
    all pledges, liens and encumbrances. The Common Stock issuable upon exercise
    of the Warrants (the “Warrant Shares”) has been duly authorized
    and reserved and, when issued upon exercise of the Warrants in accordance
    with the terms of the Warrants, will be validly issued, fully paid and non-assessable
    and free and clear of all pledges, liens and encumbrances. The Unit Common
    Stock, the Warrants and the Warrant Shares collectively are referred to herein
    as the “Securities”. No preemptive right, co-sale right,
    right of first refusal or other similar right exists with respect to the
    Securities or the issuance and sale thereof. No further approval or authorization
    of any stockholder or the Board of Directors of the Company is required for
    the issuance and sale of the Securities. Except as set forth in the SEC Documents,
    no holder of any of the securities of the Company has any rights (“demand,” “piggyback” or
    otherwise) to have such securities registered by reason of the intention
    to file, filing or effectiveness of a Registration Statement (as defined
    in Section 5.1 hereof).

 

 

5

2.6     Legal Proceedings. Except as disclosed in the SEC Documents, there is no action, suit or proceeding before any court, governmental agency or body, domestic or foreign, now pending or, to the knowledge of the Company or any of its Subsidiaries, overtly
 threatened against the Company or its Subsidiaries, which, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect on the Company and its Subsidiaries taken as a whole.

2.7     No Violations. Neither the Company nor any of its Subsidiaries is in violation of its charter, bylaws, or other organizational document, or is in violation of any law, administrative regulation, ordinance or order of any court or governmental agency, arbitration panel
 or authority applicable to the Company or any of its Subsidiaries, which violation, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect on the Company and its Subsidiaries taken as a whole, or is in default (and there
 exists no condition which, with or without the passage of time or giving of notice or both, would constitute a default) in the performance of any bond, debenture, note or any other evidence of indebtedness in any indenture, mortgage, deed of trust or any other material
 agreement or instrument to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound or by which the properties of the Company are bound, which, individually or in the aggregate, has had or would reasonably be
 expected to have a Material Adverse Effect on the Company and its Subsidiaries taken as a whole.

2.8     Governmental Permits, Etc. The Company and its Subsidiaries possess all necessary franchises, licenses, certificates and other authorizations from any foreign, federal, state or local government or governmental agency, department or body that are currently
 necessary for the operation of their respective business as currently conducted, except where such failure to possess has not and would not reasonably be expected to have a Material Adverse Effect (individually or in the aggregate) on the Company and its Subsidiaries taken as
 a whole.

2.9     Intellectual Property.
    The Company and its Subsidiaries own or possess sufficient rights to use
    all patents, patent rights, trademarks, copyrights, licenses, inventions,
    trade secrets, trade names and know-how that are necessary for the conduct
    of their respective businesses as now conducted except where such failure
    to own or possess has not and would not reasonably be expected to have a
    Material Adverse Effect (individually or in the aggregate) on the Company
    and its Subsidiaries taken as a whole (the “Company Intellectual
 Property). Except as set forth in the SEC Documents, (i) neither the Company nor any of its Subsidiaries has received any written notice of, or has any knowledge of, any infringement by the Company or its Subsidiaries of intellectual property rights of any third party that,
 individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect on the Company and its Subsidiaries taken as a whole and (ii) neither the Company nor any of its Subsidiaries has received any written notice of any infringement by a
 third party of any Company Intellectual Property that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect on the Company and its Subsidiaries taken as whole.

2.10     Financial Statements. The consolidated financial statements of the Company and its Subsidiaries and the related notes thereto included in the SEC Documents present fairly, in all material respects, the financial position of the Company as of the dates indicated and
 the results of its operations and cash flows for the periods therein specified. Except as set forth in such financial

 

6

statements, such financial statements (including the related notes) have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis throughout the periods therein specified.

2.11     No Material Adverse Change.
    Except as publicly disclosed in the SEC Documents, press releases or in other “public disclosures” as
    such term is defined in Section 101(e) of Regulation FD of the Exchange Act,
    since June 30, 2003 there has not been (i) any Material Adverse Effect on
    Company or any of its Subsidiaries (it being understood that the Company
    has incurred operating losses), (ii) any obligation, direct or contingent,
    that is material to the Company and its Subsidiaries taken as a whole, incurred
    by the Company or any
 of its Subsidiaries, except obligations incurred in the ordinary course of business,
    (iii) any dividend or distribution of any kind declared, paid or made on
    the capital stock of the Company, or (iv) any loss or damage (whether or
    not insured) to the physical property of the Company or any of its Subsidiaries
    which has been sustained which has had a material adverse effect on the business,
    assets, financial condition or results of operation of the Company and its
  Subsidiaries taken as a whole.

2.12     NASDAQ Listing.
    The Company’s Common Stock is registered pursuant to Section 12(g) of
    the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National
    Market (the “Nasdaq National Market”), and the Company has taken no action designed to,
 or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor to the Company’s
 knowledge is the National Association of Securities Dealers, Inc. (“NASD”)
 currently contemplating terminating such listing. The Company and the Common
 Stock meet the criteria for continued listing and trading on the Nasdaq National
 Market.

2.13     S-3 Compliance. The Company meets the requirements for the use of Form S-3 for the registration of the resale of the Unit Common Stock and the Warrant Shares by the Investors.

2.14     No Manipulation of Stock. The Company has not taken and will not, in violation of applicable law, take, any action designed to or that might reasonably be expected to cause or result in stabilization or manipulation of the price of the Common Stock to facilitate
 the sale or resale of the Unit Common Stock or the Warrant Shares.

2.15     Insurance. The Company and each of its Subsidiaries maintains and will continue to maintain insurance against loss or damage by fire or other casualty and such other insurance, including, but not limited to, product liability insurance, in such amounts and
 covering such risks as is reasonably adequate consistent with industry practice for the conduct of their respective businesses and the value of their respective properties.

2.16     Tax Matters. The Company and each of its Subsidiaries has timely filed all material federal, state, local and foreign income and franchise and other tax returns required to be filed by any jurisdiction to which it is subject and has paid all taxes due in accordance
 therewith, and no tax deficiency has been determined adversely to the Company or any of its Subsidiaries which has had (nor does the Company or any of its Subsidiaries have any knowledge of any tax deficiency which, if determined adversely to the Company or any of its
 Subsidiaries, would reasonably be expected to have) a Material Adverse Effect on the Company or any of its Subsidiaries taken as a whole.

 

7

2.17     Investment Company.
    The Company is not an “investment company” within the meaning of
    such term under the Investment Company Act of 1940 and the rules and regulations
  of the SEC thereunder.

2.18     No Registration. Assuming the accuracy of the representations and warranties made by, and compliance with the covenants of, the Investors in Article III hereof, no registration of the Units under the Securities Act is required in connection with the offer and sale
 of the Units by the Company to the Investors as contemplated by this Agreement.

2.19     No Directed Selling Efforts or General Solicitation. Neither the Company nor any person or entity acting on its behalf has conducted any general solicitation or general advertising (as those terms are used in Regulation D promulgated under the Securities Act) in
 connection with the offer or sale of any of the Securities.

2.20     No Integrated Offering. Neither the Company nor any of its affiliates, nor any person or entity acting on its or their behalf has, directly or indirectly, made any offers or sales of any Company security or solicited any offers to buy any security, under circumstances
 that would adversely affect reliance by the Company on Section 4(2) of the Securities Act for the exemption from registration for the transactions contemplated hereby or would require registration of the Securities under the Securities Act.

2.21     Questionable Payments.
    Neither the Company nor any of its Subsidiaries nor, to the Company’s
    knowledge, any of their respective current or former directors, officers,
    employees, agents, stockholders owning at least 10% of the outstanding capital
    stock of the Company, or other persons or entities acting on behalf of the
    Company or any Subsidiary, has on behalf of the Company or any Subsidiary
    or in connection with their respective businesses: (a) used any corporate
    funds for unlawful contributions, gifts, entertainment or other
 unlawful expenses relating to political activity; (b) made any direct or indirect
    unlawful payments to any governmental officials or employees from corporate
    funds; (c) established or maintained any unlawful or unrecorded fund of corporate
    monies or other assets; (d) made any false or fictitious entries on the books
    and records of the Company or any Subsidiary; or (e) made any unlawful bribe,
    rebate, payoff, influence payment, kickback or other unlawful payment of
  any nature.

2.22     Transactions with Affiliates. Except as disclosed in the SEC Documents, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company or
 any Subsidiary (other than as holders of stock options and/or warrants, or for services as employees, officers, consultants or directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or
 personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or
 partner.

2.23     Internal Controls.
    The Company and the Subsidiaries maintain a system of internal accounting
    controls sufficient to provide reasonable assurance that (i) transactions
    are executed in accordance with management’s general or specific authorizations,
  (ii) transactions are recorded as

 

8

necessary to permit preparation of
    financial statements in conformity with generally accepted accounting principles
    and to maintain asset accountability, (iii) access to assets is permitted
    only in accordance with management’s general or specific authorization,
    and (iv) the recorded accountability for assets is compared with the existing
    assets at reasonable intervals and appropriate action is taken with respect
 to any differences.

2.24     Disclosures. Neither the Company nor any person or entity acting on its behalf has provided the Investor or its agent or counsel with any information that constitutes material, non-public information.

	ARTICLE III

      

        REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE INVESTOR

The Investor represents, warrants and covenants to the Company as follows:

3.1     Securities Law Representations and Warranties.

  (a)     The
      Investor is an “accredited investor” as defined in Regulation
      D under the Securities Act and the Investor has the knowledge, sophistication
      and experience necessary to make, and is qualified to make decisions with
      respect to, investments in shares presenting an investment decision like
      that involved in the purchase of the Securities, including investments
      in
      securities issued by the Company and investments in comparable companies,
      can bear the economic risk of a total loss of its investment in the Securities
      and has requested, received, reviewed and considered all information it
  deemed relevant in making an informed decision to purchase the Securities;

  (b)     The
        Investor (i) is acquiring the Units (including the Unit Common Stock and
        Warrants) and (ii) upon exercise of the Warrants held by it, will acquire
        the Warrant Shares then issuable upon exercise thereof for its own account
        for investment only and not with a view towards, or for resale in connection
        with, the public sale or distribution thereof in any circumstance that
        could cause the offering of the Unit Common Stock and the Warrants and
        the sale
        of the Unit Common Stock and the Warrants hereunder to not be exempt from
  registration pursuant to Section 4(2) of the Securities Act;

  (c)     The
  Investor was not organized for the specific purpose of acquiring the Securities;

  (d)     The
      Investor will not, directly or indirectly, offer, sell, pledge, transfer
      or otherwise dispose of (or solicit any offers to buy, purchase or otherwise
      acquire or take a pledge of) any of the Securities except in compliance with
      the Securities Act, applicable state securities laws and the respective rules
  and regulations promulgated thereunder;

  (e)     The
      Investor understands that the Securities are being offered and sold to it
      in reliance on specific exemptions from the registration requirements of
      the United States federal and state securities laws and that the Company
      is relying upon the truth and accuracy of, and the Investor’s compliance
  with, representations, warranties, agreements, acknowledgements and

 

 

9

understandings of the Investor set forth herein and in the applicable Warrant in order to determine the availability of such exemptions and the eligibility of the Investor to acquire the Securities;

(f)     The
    Investor understands that no United States federal or state agency or any
    other government or governmental
  agency has passed on or made any recommendation or endorsement of the Securities
  or the fairness or suitability of an investment in the Securities nor have
  such authorities passed upon or endorsed the merits of the offering of the
  Securities; and 
  

    (g)     The
        Investor acknowledges that the Company has represented that no action
        has been or will be taken in any jurisdiction outside the United States
        by the Company that would permit an offering of the Securities, or possession
        or distribution of offering materials in connection with the issue of
        the Securities, in any jurisdiction outside the United States where action
        for that purpose is required. If the Investor is located or domiciled
        outside the United States it agrees to comply with all applicable laws
        and regulations in each foreign jurisdiction in which it purchases, offers,
        sells or delivers Securities or has in its possession or distributes
        any offering material, in all cases at its own expense.

    
  3.2     Legends.

  (a)     The
      Investor understands that, until the end of the holding period under Rule
      144(k) of the Securities Act (or any successor provision) the Warrant (and
      all securities issued in exchange therefor or in substitution thereof,
      other than Warrant Shares, which shall bear the legend set forth in Section
      3.2(b)
      of this Agreement, if applicable) shall bear a legend in substantially
      the following form:

   

THE SECURITIES REPRESENTED
    HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
    (THE “SECURITIES ACT”) OR APPLICABLE STATE SECURITIES LAWS. THE
    SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, ASSIGNED, PLEDGED
    OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR
    THE SECURITIES UNDER THE SECURITIES ACT, OR TRIKON TECHNOLOGIES, INC. (THE “COMPANY”)
    SHALL HAVE RECEIVED AN OPINION FROM COUNSEL REASONABLY SATISFACTORY TO THE
    COMPANY THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND
    UNDER THE PROVISIONS OF APPLICABLE FEDERAL AND STATE SECURITIES LAWS IS NOT
    REQUIRED.

The legend set forth above shall be removed and the Company shall issue a new certificate evidencing a new Warrant of like tenor and aggregate number of shares and which shall not bear the restrictive legends required by this Section 3.2(a): (i) if, in connection with a
 sale transaction, such holder provides the Company with an opinion of counsel reasonably acceptable to the Company to the effect that a public sale, assignment or transfer of the Warrant, as appropriate, may be made without registration under the Securities Act, or (ii) upon
 expiration of the two-year holding period

 

10

under Rule 144(k) of the Securities
    Act (or any successor rule); provided that the Investor is not and has not
    been within 3 months prior to such date, an “affiliate” of the Company (as such term is defined in Rule 144 of the Securities Act) (in which event such holding period
 shall be deemed to have expired when such Investor has not been an “affiliate” of
 the Company for the preceding three-month period). The Company shall not require
 such opinion of counsel for the sale of Warrants in accordance with Rule 144
 of the Securities Act in the event that the Investor provides such representations
 that the Company shall reasonably request confirming compliance with the requirements
 of Rule 144.

  (b)     Subject
      to the terms of this clause (b), any certificate representing the Unit
      Common Stock or Warrant Shares shall bear a legend in substantially the
      following
form:

THE SECURITIES REPRESENTED
      HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
      (THE “SECURITIES ACT”) OR APPLICABLE STATE SECURITIES LAWS. THE
      SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, ASSIGNED, PLEDGED
      OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR
      THE SECURITIES UNDER THE SECURITIES ACT, OR TRIKON TECHNOLOGIES, INC. (THE “COMPANY”)
      SHALL HAVE RECEIVED AN OPINION FROM COUNSEL REASONABLY SATISFACTORY TO THE
      COMPANY THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND
      UNDER THE PROVISIONS OF APPLICABLE FEDERAL AND STATE SECURITIES LAWS IS NOT
    REQUIRED.

The legend set forth above shall
    be removed and the Company’s transfer agent shall issue the Unit Common Stock or the Warrant Shares, as applicable, without such legend to the holder of the Unit Common Stock or Warrant Shares upon which it is stamped, as
 applicable (i) if the Unit Common Stock or the Warrant Shares, as applicable, have been resold or transferred pursuant to the Registration Statement contemplated by Section 5 and the Registration Statement was effective at the time of such transfer, (ii) if, in connection with a
 sale transaction, such holder provides the Company with an opinion of counsel reasonably acceptable to the Company to the effect that a public sale, assignment or transfer of the Unit Common Stock and Warrant Shares, as applicable, may be made without registration under
 the Securities Act, or (iii) upon expiration of the applicable two-year holding period under Rule 144(k) of the Securities Act (or any successor rule); provided
 that the Investor is not and has not been within 3 months prior to such date, an “affiliate” of the Company (as such
 term is defined in Rule 144 of the Securities Act) (in which event such holding period shall be deemed to have expired when such Investor has not been an “affiliate” of
 the Company for the preceding three-month period). The Company shall not require
 such opinion of counsel for the sale of the Unit Common Stock or the Warrant
 Shares in accordance with Rule 144 of the Securities Act, provided that the
 Seller provides such representations that the Company shall reasonably request
 confirming compliance with the requirements of Rule 144.
 The Company shall irrevocably instruct its transfer agent that, upon presentation
 to the transfer agent of a completed

 

11

Certificate of Subsequent Sale in the form attached hereto as Exhibit E, the transfer agent shall thereupon re-issue a stock certificate representing the number of shares sold without the legend set forth above.

(c)     The
    Investor understands that, in the event Rule 144(k) as promulgated under
    the Securities Act (or any successor rule) is amended to change the two-year
    period under Rule 144(k) (or the corresponding period under any successor
    rule), (i) each reference in Sections 3.2(a) and (b) of this Agreement to “two
    (2) years” or the “two-year period” shall be deemed for all
    purposes of this Agreement to be references to such changed period, and (ii)
    all corresponding references in the Securities shall be deemed for all purposes
    to be references to the changed period, provided that such changes shall
    not become effective if they are otherwise prohibited by, or would otherwise
    cause a violation of, the then-applicable federal securities laws. The Investor
    acknowledges that, with respect to the Warrant Shares, the two (2) year holding
    period referred to in Section 3.3(b) shall commence on the date the related
    Warrant is exercised.

3.3     Authorization; Enforcement; Validity.
    The Investor has full right, power, authority and capacity to enter into
    this Agreement and to consummate the transactions contemplated hereby and
    has taken all necessary action to authorize the execution, delivery and performance
    of this Agreement. This Agreement constitutes a valid and binding obligation
    of the Investor enforceable against the Investor in accordance with its terms,
    except (i) to the extent rights to indemnity and contribution may be limited
    by state or federal securities laws
 or the public policy underlying such laws, (ii) enforceability may be limited
    by applicable bankruptcy, insolvency, reorganization, fraudulent conveyance,
    moratorium or similar laws affecting creditors’ and contracting parties’ rights
    generally and (iii) enforceability may be limited by general principles of
    equity (regardless of whether such enforceability is considered in a proceeding
  in equity or at law).

3.4     Certain Trading Limitations.
    The Investor (i) represents that on and from the date the Investor first
    became aware of the offering of the Unit Common Stock and the Warrants until
    the date hereof he, she or it has not and (ii) covenants that for the period
    commencing on the date hereof and ending at such time that the Company publicly
    announces the offering of the Unit Common Stock and the Warrants he, she
    or it will not, engage in any hedging or other transaction which is designed
    to or could reasonably be expected to
 lead to or result in, or be characterized as, a sale, an offer to sell, a solicitation
    of offers to buy, disposition of, loan, pledge or grant of any right with
    respect to (collectively, a “Disposition”) Common Stock
    of the Company by the Investor or any other person or entity in violation
    of the Securities Act. Such prohibited hedging or other transactions would
    include without limitation effecting any short sale or having in effect any
    short position (whether or not such sale or position is against the box and
    regardless of when such position was
 entered into) or any purchase, sale or grant of any right (including without
    limitation any put or call option) with respect to the Common Stock of the
    Company or with respect to any security (other than a broad-based market
    basket or index) that includes, relates to or derives any significant part
  of its value from the Common Stock of the Company.

3.5     No Sale of Securities. The Investor hereby covenants with the Company not to make any sale of the Securities without (i) complying with the provisions of this Agreement, including Section 5.3 hereof or (ii) without satisfying the requirements of the Securities Act
 and the rules and

 

12

regulations promulgated thereunder, including, without limitation, causing the prospectus delivery requirement under the Securities Act to be satisfied, if applicable. The Investor acknowledges that there may occasionally be times when the Company, based on the advice of its
 counsel, determines that, subject to the limitations of Section 5.3, it must suspend the use of the prospectus forming a part of the Registration Statement until such time as an amendment to the Registration Statement has been filed by the Company and declared effective by the
 SEC or until the Company has amended or supplemented such prospectus.

3.6     Registration Questionnaire. The Investor has completed or caused to be completed the Registration Questionnaire attached hereto as Exhibit C and on the signature page for use in preparation of the Registration Statement and the answers to the Questionnaire and
 on such signature page are true and correct in all material respects as of the date of this Agreement and will be true and correct as of the effective date of the Registration Statement; provided
 that the Investor shall be entitled to update such information by providing written
 notice thereof to the Company prior to the effective date of the Registration Statement.

3.7     Investor Suitability Questionnaire. The information contained in the Investor Suitability Questionnaire in the form attached as Exhibit D delivered by the Investor in connection with this Agreement is complete and accurate in all respects.

3.8     No Advice. The Investor understands that nothing in this Agreement or any other materials presented to the Investor in connection with the purchase and sale of the Units constitutes legal, tax or investment advice. The Investor has consulted such legal, tax and
 investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of the Units.

3.9     Ownership of Common Stock. As of the date hereof, the Investor and its affiliated entities owns (beneficially or of record), the shares of capital stock of the Company set forth on Schedule B hereto.

	ARTICLE IV

      

        COVENANTS

4.1     Listing of Shares. The Company shall comply with all requirements of the NASD with respect to the issuance of the Securities and the listing of the Unit Common Stock and the Warrant Shares on the Nasdaq National Market. In furtherance thereof, the Company
 shall use its commercially reasonable efforts to take such actions as may be necessary as soon as practicable after the Closing Date to file with the Nasdaq National Market an application or other document required by the Nasdaq National Market and pay all applicable fees for
 the listing of the Unit Common Stock and the Warrant Shares with the Nasdaq National Market. The Company knows of no reason why the Unit Common Stock and Warrant Shares will not be eligible for listing on the Nasdaq National Market.

 

13

4.2     Form D. The Company agrees to file one or more Forms D with respect to the Securities on a timely basis as required under Regulation D under the Securities Act to claim the exemption provided by Rule 506 of Regulation D.

4.3     Certain Future Financings and Related Actions. For a period of ninety (90) days after the date the Registration Statement is declared effective by the SEC, the Company shall not offer, sell, contract to sell or issue (or engage any person to assist the Company in
 taking any such action) any equity securities or securities convertible into, exchangeable for or otherwise entitling the holder to acquire, any Common Stock; provided, however, that nothing in this Section 4.4(b) shall prohibit the Company from issuing securities (1) to
 employees, directors, officers, advisors or consultants of the Company or any of its Subsidiaries; (2) upon exercise of conversion, exchange, purchase or similar rights issued, granted or given by the Company and outstanding as of the date of this Agreement; or (3) pursuant to
 a strategic partnership or alliance agreement, loan agreement, equipment lease or similar commercial agreement (including licensing and similar arrangements).

	ARTICLE V

      REGISTRATION OF SHARES; COMPLIANCE WITH THE SECURITIES
        ACT

5.1     Registration Procedures and Expenses. The Company shall:

  (a)     Subject
      to receipt of necessary information from the Investors, including the Registration
      Statement Questionnaire, use reasonable best efforts to prepare and file
      with the SEC, within 30 days after the Closing Date, a registration statement
      (the “Registration Statement”) on Form S-3 to enable the
      resale of the Registrable Shares by the Investors on a delayed or continuous
      basis under Rule 415 of the Securities Act. “Registrable Shares” means
      (a) each share of Unit Common Stock; and (b) each Warrant Share until the
      earlier of: (1) the date on which such share has been resold or otherwise
      transferred pursuant to the Registration Statement; (2) the date on which
      such share is transferred in compliance with Rule 144 under the Securities
      Act or may be sold or transferred pursuant to Rule 144 under the Securities
      Act (or any other similar provisions then in force) without any volume
      or manner of sale restrictions thereunder; or (3) the date on which such
      share
      ceases to be outstanding (whether as a result of redemption, repurchase
      and cancellation or otherwise).

  (b)     use
      reasonable best efforts, subject to receipt of necessary information from
      the Investors, including the Registration Statement Questionnaire, to cause
      the Registration Statement to become effective within 90 days of the Closing
      Date;

  (c)     use
    reasonable best efforts to prepare and file with the SEC such amendments
    and supplements to the Registration Statement and the Prospectus (as defined
    in Section 5.4 below) used in connection therewith and take all such other
    actions as may be necessary to keep the Registration Statement current and
    effective for a period (the “Registration Period”) not exceeding,
    with respect to the Investor’s Registrable Shares, the earlier of (i)
    the second anniversary of the Closing Date (provided, however,
    that with respect to Registrable Shares that are Warrant Shares, the foregoing
    date shall be the second anniversary of the date the related Warrant was
  exercised), (ii) the date on

 

 

14

which all Registrable Shares then held by the Investor may be sold or transferred in compliance with Rule 144 under the Securities Act (or any other similar provisions then in force) without any volume or manner of sale restrictions thereunder, and (iii) such time as all
 Registrable Shares held by the Investor have been sold (A) pursuant to a registration statement, (B) to or through a broker or dealer or underwriter in a public distribution or a public securities transaction, or (C) in a transaction exempt from the registration and prospectus
 delivery requirements of the Securities Act under Section 4(1) thereof so that all transfer restrictions and restrictive legends with respect thereto, if any, are removed upon the consummation of such sale;

(d)     promptly
    furnish to the Investor with respect to the Registrable Shares registered
    under the
  Registration Statement such reasonable number of copies of the Registration
  Statement and Prospectus, including any supplements to or amendments of the
  Prospectus or Registration Statement, in order to facilitate the public sale
  or other disposition of all or any of the Registrable Shares by the Investor; 
  

    (e)     promptly
        take such action as may be necessary to qualify, or obtain, an exemption
        for the Registrable Shares under such of the state securities laws of
        United States jurisdictions as shall be necessary to qualify, or obtain
        an exemption for, the sale of the Registrable Shares in states specified
        in writing by the Investor; provided, however, that the
        Company shall not be required to qualify to do business or consent to
        service of process in any jurisdiction in which it is not now so qualified
        or has not so consented;

    (f)     bear
        all expenses in connection with the procedures in paragraph (a) through
        (c) of this Section 5.1 and the registration of the Registrable Shares
        pursuant to the Registration Statement, regardless of whether a Registration
        Statement becomes effective, including without limitation: (i) all registration
        and filing fees and expenses (including filings made with the NASD);
        (ii) fees and expenses of compliance with federal securities and state “blue
        sky” or securities laws; (iii) expenses of printing (including printing
        certificates for the Registrable Shares and Prospectuses); (iv) all application
        and filing fees in connection with listing the Registrable Shares on
        the Nasdaq National Market; and (v) all fees and disbursements of counsel
        of the Company and independent certified public accountants of the Company; provided, however,
        that the Investor shall be responsible for paying the underwriting commissions
        or brokerage fees, and taxes of any kind (including, without limitation,
        transfer taxes) applicable to any disposition, sale or transfer of the
        Investor’s Registrable Shares. The Company shall, in any event,
        bear its internal expenses (including, without limitation, all salaries
        and expenses of its officers and employees performing legal or accounting
        duties); and

    (g)     advise
        the Investors, within two business days by e-mail, fax or other type
        of communication, and, if requested by such person, confirm such advice
        in writing: (i) after it shall receive notice or obtain knowledge of
        the issuance of any stop order by the SEC delaying or suspending the
        effectiveness of the Registration Statement or of the initiation or threat
        of any proceeding for that purpose, or any other order issued by any
        state securities commission or other regulatory authority suspending
        the qualification or exemption from qualification of such Registrable
        Shares under state securities or “blue sky” laws; and it will
        promptly use its reasonable best efforts to prevent the issuance of any
        stop order or other order or to obtain its withdrawal at the earliest
        possible moment if such stop order or other order should be issued; and
        (ii) when the

     

 

15

Prospectus or any supplements to or amendments of the Prospectus have been filed, and, with respect to the Registration Statement or any post-effective amendment thereto, when the same has become effective.

5.2     Delay in Effectiveness of Registration Statement.
    The Company further agrees that, (i) in the event the Registration Statement
    has not been filed with the SEC within 30 days after the Closing Date, the
    Company shall pay to the Investor liquidated damages in the amount of 1.0%
    of the total purchase price of the Units purchased by the Investor pursuant
    to this Agreement; (ii) in the event the Registration Statement has not been
    filed with the SEC within 60 days after the Closing Date, the Company shall
    pay to the Investor additional
 liquidated damages in the amount of 1.0% of the total purchase price of the
    Units purchased by the Investor pursuant to this Agreement; and (iii) the
    Company shall pay to the Investor liquidated damages in the amount of 1.0%
    of the total purchase price of the Units purchased by the Investor pursuant
    to this Agreement in the event the Registration Statement has not been declared
    effective by the SEC within 90 days after the Closing Date and an additional
    liquidated damages payment of 1.0% of the total purchase price of the Units
    purchased by the
 Investor pursuant to this Agreement for each 30-day period thereafter (pro rated
    for any period of less than 30 days) until the Registration Statement has
    been declared effective; although in no event shall the aggregate penalty
    in any 30-day period exceed 1% of the total purchase price of the Units purchased
    by the Investor. The Company shall deliver the cash payments described in
    clauses (i), (ii) and (iii) to the Investor by the fifth business day after
    the occurrence of the event described in (i), (ii) or (iii), as applicable.
    Notwithstanding
 anything to the contrary in Section 5.2 or any other provision of this Agreement,
    payment of cash as provided in this Section 5.2 shall be the Investor’s
    sole and exclusive monetary remedy in the event of the occurrence of an event
    described in (i), (ii) or (iii); provided,
 however, that the Investor shall retain all equitable remedies then available to it.

5.3     Transfer of Shares; Suspension.

(a)     The
    Investor agrees that it will not effect any Disposition of the Securities
    or its right to purchase
  the Registrable Shares that would constitute a sale within the meaning of the
  Securities Act, except as contemplated in the Registration Statement referred
  to in Section 5.1 or in accordance with the Securities Act, and that it will
  promptly notify the Company of any changes in the information set forth in
  the Registration Statement regarding the Investor or its plan of distribution. 
  

    (b)     Except
        in the event that paragraph (c) below applies, the Company shall, at
        all times during the Registration Period, promptly (i) prepare and file
        from time to time with the SEC a post-effective amendment to the Registration
        Statement or a supplement to the related Prospectus or a supplement or
        amendment to any document incorporated therein by reference or file any
        other required document so that such Registration Statement will not
        contain an untrue statement of a material fact or omit to state a material
        fact necessary to make the statements therein not misleading, and so
        that, as thereafter delivered to purchasers of the Registrable Securities
        being sold thereunder, such Prospectus will not contain an untrue statement
        of a material fact or omit to state a material fact required to be stated
        therein or necessary to make the statements therein, in light of the
        circumstances under which they were made, not misleading; (ii) provide
        the Investor copies of any documents filed pursuant to Section 5.3(b)(i);
        and (iii) inform the Investor that the Company has complied with its
        obligations in Section 5.3(b)(i) (or that, if the Company has filed a
        post-effective

     

 

16

amendment to the Registration Statement which has not yet been declared effective, the Company will notify the Investor to that effect, will use its commercially reasonable efforts to secure the effectiveness of such post-effective amendment as promptly as possible and will
 promptly notify the Investor pursuant to Section 5.3(b)(iii) hereof when the amendment has become effective).

(c)     Subject
    to paragraph (d) below, in the event of (i) any request by the SEC or any
    other federal or state governmental authority during the period of effectiveness
    of the Registration Statement for amendments or supplements to a Registration
    Statement or related Prospectus or for additional information; (ii) the issuance
    by the SEC or any other federal or state governmental authority of any stop
    order suspending the effectiveness of a Registration Statement or the initiation
    of any proceedings for that purpose; (iii) the receipt by the Company of
    any notification with respect to the suspension of the qualification or exemption
    from qualification of any of the Registrable Shares for sale in any jurisdiction
    or the initiation or threatening of any proceeding for such purpose; or (iv)
    any event or circumstance which necessitates the making of any changes in
    the Registration Statement or Prospectus, or any document incorporated or
    deemed to be incorporated therein by reference, so that, in the case of the
    Registration Statement, it will not contain any untrue statement of a material
    fact or omit to state a material fact required to be stated therein or necessary
    to make the statements therein not misleading, and that in the case of the
    Prospectus, it will not contain any untrue statement of a material fact or
    omit to state a material fact necessary to make the statements therein, in
    the light of the circumstances under which they were made, not misleading,
    then the Company shall deliver a notice in writing to the Investor (the “Suspension
    Notice”) to the effect of the foregoing and, upon receipt of such
    Suspension Notice, the Investor will refrain from selling any Registrable
    Shares pursuant to the Registration Statement (a “Suspension”)
    until the Investor’s receipt of copies of a supplemented or amended
    Prospectus prepared and filed by the Company, or until it is advised in writing
    by the Company that the current Prospectus may be used. In the event of any
    Suspension, the Company will use its commercially reasonable efforts, consistent
    with the best interests of the Company and its stockholders, to cause the
    use of the Prospectus so suspended to be resumed as soon as reasonably practicable
    after the delivery of a Suspension Notice to the Investor.
  
  

    (d)     In
        the event the Investor is prohibited from selling Registrable Shares
        under the Registration Statement as a result of Suspensions on more than
        two occasions of more than 45 days each in any twelve-month period, the
        Company shall pay to the Investor liquidated damages in the amount of
        1.0% of the total purchase price of the Unit Common Stock then held by
        the Investor if, as a result of such Suspensions, the Investor is prohibited
        from selling Registrable Shares under the Registration Statement for
        a period that exceeds 60 consecutive days or 120 days in the aggregate
        in any twelve-month period and for each 30-day period thereafter during
        which such prohibition continues; provided that in no event shall
        the Company be obligated to pay more than 1.0% in any 30-day period (assuming
        for the purposes of this clause (d) that the purchase price of the Unit
        Common Stock is equal to $5.00 per share).

    (e)     In
        the event of a sale of Registrable Shares by the Investor under the Registration
        Statement, the Investor must also deliver to the Company’s transfer
        agent, with a copy to the Company, a Certificate of Subsequent Sale substantially
        in the form attached hereto as Exhibit E, so that the Registrable
        Shares may be properly transferred.

 

 

17

5.4     Indemnification.
    For the purpose of this Section 5.4, the term “Registration Statement” shall
    include any preliminary or final prospectus, exhibit, supplement or amendment
    included in or relating to the Registration Statement referred to in Section
    5.1 and the term “Rules and Regulations” means the rules
  and regulations promulgated under the Securities Act.

(a)     Indemnification
    by the Company. The Company agrees to indemnify and hold harmless the
    Investor and each person, if any, who controls the Investor within the meaning
    of the Securities Act, against any losses, claims, damages, liabilities or
    expenses to which the Investor or such controlling person may become subject,
    under the Securities Act, the Exchange Act, or any other federal or state
    statutory law or regulation insofar as such losses, claims, damages, liabilities
    or expenses (or actions in respect thereof as contemplated below) arise out
    of or are based upon (i) any untrue statement or alleged untrue statement
    of any material fact contained in the Registration Statement, including the
    Prospectus, financial statements and schedules, and all other documents filed
    as a part thereof, as amended at the time of effectiveness of the Registration
    Statement, including any information deemed to be a part thereof as of the
    time of effectiveness pursuant to paragraph (b) of Rule 430A, or pursuant
    to Rule 434 of the Rules and Regulations, or the Prospectus, in the form
    first filed with the Commission pursuant to Rule 424(b) of the Regulations,
    or filed as part of the Registration Statement at the time of effectiveness
    if no Rule 424(b) filing is required (the “Prospectus”),
    or any amendment or supplement thereto (ii) the omission or alleged omission
    to state in any of them a material fact required to be stated therein or
    necessary to make the statements in any of them (in the case of the Prospectus
    only, in light of the circumstances under which they were made), not misleading,
    or (iii) any inaccuracy in the representations and warranties of the Company
    contained in this Agreement, or any failure of the Company to perform its
    obligations under this Agreement, and will reimburse the Investor and each
    such controlling person for any legal and other expenses as such expenses
    are reasonably incurred by the Investor or such controlling person in connection
    with investigating, defending, settling, compromising or paying any such
    loss, claim, damage, liability, expense or action; provided, however, that
    the Company will not be liable in any such case to the extent that any such
    loss, claim, damage, liability or expense arises out of or is based upon
    (i) an untrue statement or alleged untrue statement or omission or alleged
    omission made in the Registration Statement, the Prospectus or any amendment
    or supplement of the Registration Statement or Prospectus in reliance upon
    and in conformity with written information furnished to the Company by or
    on behalf of the Investor expressly for use in the Registration Statement
    or the Prospectus, or (ii) the failure of the Investor to comply with the
    covenants and agreements contained in Sections 3.5 or 5.3 of this Agreement
    respecting resale of Securities, or (iii) the inaccuracy of any representations
    made by the Investor in this Agreement or (iv) any untrue statement or omission
    of a material fact in any Prospectus that is corrected in any subsequent
    Prospectus that was delivered to the Investor before the pertinent sale or
    sales by the Investor. 
  

   (b)     Indemnification
         by the Investor. The Investor will indemnify and hold harmless the
         Company, each of its directors, each of its officers who sign the Registration
         Statement and each person, if any, who controls the Company within the
         meaning of the Securities Act, against any losses, claims, damages,
         liabilities or expenses to which the Company, each of its directors,
         each of its officers who sign the Registration Statement or controlling
         person may become subject, under the Securities Act, the Exchange Act,
         or any other federal or state statutory law or regulation insofar as
         such losses, claims, damages, liabilities or expenses (or actions in
         respect thereof as contemplated below) arise out of or are based upon
         (i) any failure on the part of the Investor to comply with the

 

 

18

covenants and agreements contained in Sections 3.5 or 5.3 of this Agreement respecting the sale of the Registrable Shares or (ii) the inaccuracy of any representation or warranty made by the Investor in this Agreement or (iii) any untrue or alleged untrue statement of any
 material fact contained in the Registration Statement, the Prospectus, or any amendment or supplement to the Registration Statement or Prospectus, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the
 statements therein (in the case of the Prospectus only, in light of the circumstances under which they were made), not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made
 in the Registration Statement, the Prospectus, or any amendment or supplement thereto, in reliance upon and in conformity with written information furnished to the Company by or on behalf of the Investor expressly for use therein; provided, however, that the Investor shall
 not be liable for any such untrue or alleged untrue statement or omission or alleged omission of which the Investor has delivered to the Company in writing a correction at least five business days before the occurrence of the transaction from which such loss was incurred, and
 the Investor will reimburse the Company, each of its directors, each of its officers who signed the Registration Statement or controlling person for any legal and other expense reasonably incurred by the Company, each of its directors, each of its officers who signed the
 Registration Statement or controlling person in connection with investigating, defending, settling, compromising or paying any such loss, claim, damage, liability, expense or action for which such person is entitled to be indemnified in accordance with this Section 5.4(b).

(c)     Indemnification Procedure.

(i)     Promptly
    after receipt by an indemnified party under this Section 5.4 of notice of
    the threat or commencement
  of any action, such indemnified party will, if a claim in respect thereof is
  to be made against an indemnifying party under this Section 5.4, promptly notify
  the indemnifying party in writing of the claim; but the omission so to notify
  the indemnifying party will not relieve it from any liability which it may
  have to any indemnified party for contribution or otherwise under the indemnity
  agreement contained in this Section 5.4 except to the extent it is materially
  prejudiced as a result of such failure. 
  

    (ii)     In
        case any such action is brought against any indemnified party and such
        indemnified party seeks or intends to seek indemnity from an indemnifying
        party, the indemnifying party will be entitled to participate in, and,
        to the extent that it may wish, jointly with all other indemnifying parties
        similarly notified, to assume the defense thereof; provided, however,
        if the defendants in any such action include both the indemnified party
        and the indemnifying party and the indemnified party shall have reasonably
        concluded that there may be a conflict between the positions of the indemnifying
        party and the indemnified party in conducting the defense of any such
        action or that there may be legal defenses available to it or other indemnified
        parties that are different from or additional to those available to the
        indemnifying party, the indemnified party or parties shall have the right
        to select separate counsel to assume such legal defenses and to otherwise
        participate in the defense of such action on behalf of such indemnified
        party or parties. Upon receipt of notice from the indemnifying party
        to such indemnified party of its election so to assume the defense of
        such action, the indemnifying party will not be liable to such indemnified
        party under this Section 5.4 for any legal or other expenses subsequently
        incurred by such indemnified party in connection with the defense thereof
        unless:

 

 

19

(1)     the
    indemnified party shall have employed such counsel in connection with the
    assumption of
  legal defenses in accordance with the proviso to the preceding sentence (it
  being understood, however, that the indemnifying party shall not be liable
  for the expenses of more than one separate counsel, approved by such indemnifying
  party representing all of the indemnified parties who are parties to such action),
  or 
  

    (2)     the
        indemnifying party shall not have counsel reasonably satisfactory to
        the indemnified party to represent the indemnified party within a reasonable
        time after notice of commencement of action, in each of which cases the
        reasonable fees and expenses of counsel shall be at the expense of the
        indemnifying party. Notwithstanding the provisions of this Section 5.4,
        (A) with respect to claims made pursuant to clause (i) or clause (ii)
        of Section 5.4(b), the Investor shall not be liable for any indemnification
        obligation under this Agreement in excess of the amount of net proceeds
        received by the Investor from the sale of the Registrable Shares and
        (B) with respect to claims made pursuant to clause (iii) of Section 5.4(b),
        the Investor shall not be liable for any indemnification obligation under
        this Agreement in excess of the amount of net proceeds received by the
        Investor from the sale of the Registrable Shares giving rise to such
liability.

(d)     Contribution.
    If a claim for indemnification under this Section 5.4 is unavailable to an
    indemnified party (by reason of public policy or otherwise), then each indemnifying
    party, in lieu of indemnifying such indemnified party, shall contribute to
    the amount paid or payable by such indemnified party as a result of any losses,
    claims, damages, liabilities or expenses referred to in this Agreement, in
    such proportion as is appropriate to reflect the relative fault of the indemnifying
    party and indemnified party in connection with the actions, statements or
    omissions that resulted in such losses, claims, damages, liabilities or expenses
    as well as any other relevant equitable considerations. The relative fault
    of such indemnifying party and indemnified party shall be determined by reference
    to, among other things, whether any action in question, including any untrue
    or alleged untrue statement of a material fact or omission or alleged omission
    of a material fact, has been taken or made by, or relates to information
    supplied by, such indemnifying party or indemnified party, and the parties’ relative
    intent, knowledge, access to information and opportunity to correct or prevent
    such action, statement or omission. The amount paid or payable by a party
    as a result of any losses, claims, damages, liabilities or expenses shall
    be deemed to include, subject to the limitations set forth in this Section
    5.4, any reasonable attorneys’ or other reasonable fees or expenses
    incurred by such party in connection with any proceeding to the extent such
    party would have been indemnified for such fees or expenses if the indemnification
    provided for in this Section was available to such party in accordance with
    its terms.

The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5.4 were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the
 immediately preceding paragraph. Notwithstanding the provisions of this Section 5.4, (A) with respect to claims made pursuant to clause (i) or clause (ii) of Section 5.4(b), the Investor shall not be liable to contribute any amount in excess of the amount of net proceeds
 received by the Investor from the sale of the Registrable Shares and (B) with respect to claims made pursuant to clause (iii) of Section 5.4(b), the Investor shall not be liable to contribute any amount in excess of (X) the amount by which the net proceeds received by the
 Investor from the sale of the Registrable Shares giving rise to such liability exceeds (Y) the amount of any damages that the Investor has otherwise been required to pay by reason of such

 

20

untrue or alleged untrue statement or omission or alleged omission. No party to this Agreement guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any other party to this Agreement who was
 not guilty of such fraudulent misrepresentation.

5.5     Termination of Conditions and Obligations. The restrictions imposed by Article 3 or Article 5 upon the transferability of the Registrable Shares shall cease and terminate as to any particular number of the Registrable Shares upon the passage of two years from the
 Closing Date or at such time as an opinion of counsel satisfactory in form and substance to the Company shall have been rendered to the effect that such conditions are not necessary in order to comply with the Securities Act.

5.6     Rule 144. For a period commencing on the date hereof and ending on the last day of the Registration Period, the Company agrees with each holder of Registrable Shares to:

(a)     comply
    with the requirements of Rule 144(c) under the Securities Act with respect
    to current
  public information about the Company; and 
  

    (a)     file
        with the SEC in a timely manner all reports and other documents required
        of the Company under the Securities Act and the Exchange Act (at any
time it is subject to such reporting requirements).  

	ARTICLE VI

6.1     Notices. Except as specifically permitted by Section 5.1(g), all notices, requests, consents and other communications hereunder shall be in writing, shall be mailed (A) if within United States by first-class registered or certified airmail, or nationally recognized
 overnight express courier, postage prepaid, or by facsimile, or (B) if delivered from outside the United States, by International Federal Express or facsimile, and shall be deemed given (i) if delivered by first-class registered or certified mail domestic, three business days after so
 mailed, (ii) if delivered by nationally recognized overnight carrier, one business day after so mailed, (iii) if delivered by International Federal Express, two business days after so mailed, and (iv) if delivered by facsimile, upon electric confirmation of receipt, and shall be
 delivered as addressed as follows:

	 	 	if to the Company, to:

	 	 	 	 	 
	 	 	 	Trikon
   Technologies, Inc.

   Ringland Way

Newport, South Wales

NP18 2TA

United Kingdom

Attn: Mr. William J. Chappell

Tel: 011-44-1633-414-000

Fax: 011-44-1633-414-040    
	

	 	 	 	 
	 	 	 	with a copy to:

 

21

	 	 	 	Wilson
   Sonsini
   Goodrich & Rosati,
   Professional
   Corporation

    650 Page Mill Road

        Palo Alto, CA

        94304

        Attn: Steven V. Bernard

        Tel: (650) 493-9300

    Fax: (650) 493-6811
      

    

	 	 	 
	 	 	if to the Investor, at its address on the signature page hereto, or at such other address or addresses as may have been furnished to the Company in writing.

6.2     Changes. This Agreement may not be modified or amended except pursuant to an instrument in writing signed by the Company and the Investors.

6.3     Headings. The headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be part of this Agreement.

6.4     Severability. In case any provision contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby.

6.5     Survival of Representations, Warranties and Agreements. Notwithstanding any investigation made by any party to this Agreement, all covenants, agreements, representations and warranties made by the Company and the Investor herein shall survive the execution of
 this Agreement, the delivery to the Investor of the Units being purchased and the payment therefor.

6.6     Governing Law Consent to Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York, without giving effect to the principles of conflicts of law. Each of the parties hereto irrevocably submits to
 the exclusive jurisdiction of the courts of the State of New York located in New York County and the United States District Court for the Southern District of New York for the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and
 the transactions contemplated hereby. Service of process in connection with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. Each of the parties
 hereto irrevocably consents to the jurisdiction of any such court in any such suit, action or proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such
 courts and irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.

6.7     Entire Agreement. This Agreement and the Warrant and the documents referenced herein and therein constitute the entire agreement among the parties hereto with respect to the subject matter hereof and thereof. There are no restrictions, promises, warranties or
 undertakings, other than those set forth or referred to herein and therein. This Agreement and the Warrants supersede all prior agreements and understandings.

 

22

6.8     Finders Fees.
    Neither the Company nor the Investor nor any affiliate thereof has incurred
    any obligation which will result in the obligation of the other party to
    pay any finder’s fee or commission in connection with this transaction, except for fees payable by the
 Company to the Oppenheimer & Co. Inc.

6.9     Counterparts. This Agreement may be executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken together, shall constitute but one instrument, and shall become effective when one or more counterparts have been
 signed by each party hereto and delivered to the other party.

6.10     Successors and Assigns.
    This Agreement shall inure to the benefit of and be binding upon the successors,
    heirs, executors and administrators and permitted assigns of the parties
    hereto. With respect to transfers that are not made pursuant to the Registration
    Statement (or Rule 144 but are otherwise made in accordance with all applicable
    laws and the terms of this Agreement), the rights and obligations of the
    Investor under this Agreement shall be automatically assigned by the Investor
    to any transferee of all or any portion of the
 Investor’s Securities; provided, however, that within two business days prior to the transfer, (i) the Company is provided written notice of the transfer including the name and address of the transferee and the number of Securities transferred; and (ii) that such transferee agrees
 in writing to be bound by the terms of this Agreement as if such transferee was the Investor. Upon any transfer permitted by this Section 6.10, the Company shall be obligated to such transferee to perform all of its covenants under this Agreement as if such transferee was the
 Investor.

6.11     Expenses. Each of the Company and the Investors shall bear its own expenses in connection with the preparation and negotiation of the Agreement; provided,
        however, that the Company shall pay the reasonable fees of Lowenstein Sandler PC, counsel to the
 Investor and entities affiliated with the Investor, incurred in connection with the purchase and sale of Units by and to the Investor pursuant to this Agreement and the purchase and sale of Units by and to entities affiliated with the Investor pursuant to this same form of
 Securities Purchase Agreement entered into by the Company on the date hereof, in an amount not to exceed $5,000 in the aggregate.

6.12     Exculpation.
    Each party to this Agreement acknowledges that Brown Raysman Millstein Felder & Steiner LLP represented Oppenheimer & Co.
    Inc. in the offering and sale of Units contemplated by this Agreement and
  has not represented either the Company or the Investor.

 

23

IN WITNESS WHEREOF, the parties have caused this Securities Purchase Agreement to be duly executed as of the date first written above.

	 	“COMPANY”

    TRIKON TECHNOLOGIES, INC.

	 	 	 
	 	
    By:
    
	 
	 	      William J. Chappell

      Chief Financial Officer 	 

 

[Signatures of Investor on Following Page]

	 	“INVESTOR”

    
        

                (print full legal name of Investor)

By:

(signature of authorized representative)

Name:

Its:

Address:

Telephone:

Fax:

Email:

Tax I.D. or SSN:

Address where Units should be sent (if different

from above)

        
	 

	 	 
	 	NUMBER OF UNITS SUBSCRIBED FOR:

          

        

    AGGREGATE PURCHASE PRICE:
    

    

    

 

[signature page to Securities Purchase Agreement]EXHIBIT 10.122

 Exhibit 10.122 
  

	 

	 	 	 	 SPACEHAB, Inc.
 12130 Highway 3, Bldg. 1
 Webster, Texas 77598-1504 1.713.558.5000
 fax: 1.713.558.5960
 www.spacehab.com

  
 FOR IMMEDIATE RELEASE

  
 SPACEHAB SUBSIDIARY TO RECEIVE $17.5 MILLION TERMINATION
PAYMENT 
  
 Houston, Texas, October 22, 2003—SPACEHAB,
Incorporated (NASDAQ/NMS: SPAB), a leading provider of commercial space services, today announced that its Astrotech Space Operations subsidiary will receive a $17.5 million payment due to the termination of a payload processing contract with The
Boeing Company (NYSE: BA). 
  
 Under the contract, Astrotech provided primarily
commercial payload processing services to Boeing’s Delta Program. The contract terms provided for guaranteed quarterly payments through 2010 and included an option for Boeing to terminate the contract. Boeing exercised its termination right
effective October 1, 2003. Astrotech was in full compliance with the contract terms at the time of the termination. The $17.5 million payment to Astrotech is in accordance with the Termination For Convenience Schedule of the Boeing/Astrotech
contract. The contract termination will reduce Astrotech’s backlog by $34.9 million to $15.0 million as of October 1, 2003. 
  
 Boeing indicated that the decision to terminate the contract was based on the downturn of the commercial expendable launch market rather than performance related
considerations. Boeing announced earlier this year that it would concentrate on pursuing the U.S. Government launch market. 
  
 “We are disappointed by Boeing’s decision to terminate the contract,” said John B. Satrom, Senior Vice President and General Manager at Astrotech.
“However, we understand the rationale for their decision. We firmly believe that continued financial viability of the Delta IV program is critical to the U.S. space launch capability. Boeing has utilized our payload processing services since
1984 and we expect to provide continued support to Boeing for future Delta missions at both their Florida and Vandenberg Air Force Base facilities under future contracts.” 
  
 SPACEHAB will use the proceeds of the termination payment to service the mortgage on Astrotech’s Titusville, Florida facility and repay
funds used to complete construction of the unique five-meter class Spacecraft Processing Facility (SPF). Astrotech’s SPF has an existing mortgage of $16.5 million. Completed in early 2002, the Astrotech SPF remains the only payload processing
facility at the Kennedy Space Center/Cape Canaveral Air Force Station launch site specifically designed to accommodate the 5-meter class spacecraft and payload fairings associated with the new Boeing Delta IV and Lockheed Martin Atlas V launch
vehicle systems. 
  
 Astrotech remains under contract with Lockheed Martin
Corporation for payload processing services in its Florida facility in support of the Atlas program. The contract expires in 2006 and has four additional one-year option periods available to extend the base period of performance on the contract
through 2010. 
  
 Astrotech also provides payload processing services under
contracts to NASA, the Sea Launch Company LLC, and Orbital Sciences Corporation. The Company, which has typically provided payload processing services to the commercial market, has seen growth in its government business in recent years. In April
2003, Astrotech signed a contract with NASA to provide payload processing support for the 

 MESSENGER and Deep Impact missions. This represents the first direct contract between Astrotech and NASA for processing
support at its Florida facilities. 
  
 About SPACEHAB, Incorporated

  
 With approximately $100 million in annual revenue, SPACEHAB, Incorporated
(www.spacehab.com) is a leading provider of commercial space services. The Company develops, owns, and operates habitat and laboratory modules and cargo carriers aboard NASA’s Space Shuttles for space station resupply and research
purposes. Its Government Services business unit provides Space Station and Space Shuttle support services including orbiter crew compartment integration, stowage, and configuration management to NASA’s Johnson Space Center in Houston.
SPACEHAB’s Astrotech subsidiary provides commercial satellite processing services at facilities in California and Florida. Additionally, through The Space Store, Space Media provides space merchandise to the public and space enthusiasts
worldwide (www.thespacestore.com). 
  
 The statements in this document
may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are subject to risks and uncertainties that could cause actual
results to differ materially from those projected in the statements. In addition to those risks and uncertainties discussed herein, such risks and uncertainties include, but are not limited to, whether the Company will fully realize the economic
benefits under its U.S. National Aeronautics and Space Administration (“NASA”) and other customer contracts, whether NASA and other customers will continue to utilize the Company’s habitat modules and related commercial space assets,
whether plans to complete the International Space Station (“ISS”) are fulfilled, continued availability and use of the U.S. Space Shuttle system, technological difficulties, product demand and market acceptance risks, the effect of
economic conditions, uncertainty in government funding, the impact of competition, delays and uncertainties in future space shuttle and ISS programs, resolution of the Company’s indemnification claim with NASA arising from the loss of the
Columbia orbiter and its crew during the STS-107 mission, and other risks described in reports filed by the Company with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements.

  

	 For more information, contact:
	 	 
	 Kimberly Campbell
	 	Julia A. Pulzone
	 Director of Marketing
	 	Chief Financial Officer
	 SPACEHAB, Inc.
	 	SPACEHAB, Inc.
	 Phone 713.558.5049
	 	Phone 202.488.3500
	 Fax 713.558.5957
	 	Toll free 888.647.9543
	 campbell@spacehab.com
	 	pulzone@hqspacehab.com

  
 ###

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}]]